A mini review of noncoding RNAs in the pathogenesis of polycystic kidney disease
Authors:
Open Access
- 29 May 2025
- journal article
- review article
- Published by OAE Publishing Inc. in Journal of Translational Genetics and Genomics
- Vol. 9 (2) , 100-113
Abstract
Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys, leading to kidney enlargement and progressive renal failure. Recent advances have indicated a pivotal role of noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), circular RNAs (circRNAs) and PIWI-interacting RNAs (piRNAs), in the pathogenesis of PKD, potentially through regulating gene expression and cellular processes related to cyst formation, inflammation, and fibrosis. This review summarizes current knowledge of noncoding RNAs, explores their potential as biomarkers and therapeutic targets, and proposes potential directions for future research to further elucidate their roles in disease progression.Keywords
This publication has 112 references indexed in Scilit:
- Small RNA sequencing reveals snoRNAs and piRNA-019825 as novel players in diabetic kidney diseaseEndocrine, 2024
- Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney diseaseThe Journal of Gene Medicine, 2024
- Circ_0040994 depletion alleviates lipopolysaccharide‐induced HK2 cell injury through miR‐17‐5p/TRPM7 axisEnvironmental Toxicology, 2023
- MiR‐182 inhibits kidney fibrosis by regulating transforming growth factor β1/Smad3 pathway in autosomal dominant polycystic kidney diseaseIUBMB Life, 2020
- Safe Nanocomposite‐Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) TherapyAdvanced Healthcare Materials, 2019
- The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney diseaseInternational Urology and Nephrology, 2018
- MicroRNA501‐5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cellsJournal of Cellular Physiology, 2018
- Down‐regulation of lncRNA‐NEAT1 alleviated the non‐alcoholic fatty liver disease via mTOR/S6K1 signaling pathwayJournal of Cellular Biochemistry, 2017
- Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathyHuman Genetics, 2013
- Polycystic Kidney Disease, Autosomal Dominant2005